Medical Management of Type 2 Diabetes
()
About this ebook
This new edition of Medical Management of Type 2 Diabetes provides care providers with the answers to their questions about implementing care. All of the contributors are experts in their fields, and they define the disease, including the progressive nature of type 2 diabetes; cardiovascular, microvascular, and neurological complications; care methodologies for special situations; and behavior change. All guidelines and standards have been updated with the latest developments in research, advances in medications and medical devices, and new understandings of how to effectively work with the patient.
Related to Medical Management of Type 2 Diabetes
Related ebooks
Ask the Experts: Expert Answers About Your Diabetes from the Pages of Diabetes Forecast Rating: 0 out of 5 stars0 ratingsDiabetes Management in Long-Term Settings: A Clinician's Guide to Optimal Care for the Elderly Rating: 0 out of 5 stars0 ratingsComplete Nurse's Guide to Diabetes Care Rating: 0 out of 5 stars0 ratingsAmerican Dietetic Association Guide to Eating Right When You Have Diabetes Rating: 5 out of 5 stars5/5Therapy for Diabetes Mellitus and Related Disorders Rating: 0 out of 5 stars0 ratingsMedical Management of Type 1 Diabetes, 8th Edition Rating: 0 out of 5 stars0 ratingsThe Best Life Guide to Managing Diabetes and Pre-Diabetes Rating: 4 out of 5 stars4/5Practical Diabetes Care for Healthcare Professionals Rating: 0 out of 5 stars0 ratings2019 Guide to Medications for the Treatment of Diabetes Mellitus Rating: 0 out of 5 stars0 ratingsThe Diabetes Ready Reference for Health Professionals Rating: 0 out of 5 stars0 ratingsThe Asthma and Allergy Action Plan for Kids: A Complete Program to Help Your Child Live a Full and Active Life Rating: 0 out of 5 stars0 ratingsDiabetic and the Dietitian: How to Help Your Husband Defeat Diabetes . . . Without Losing Your Mind or Marriage! Rating: 0 out of 5 stars0 ratingsManaging Type 2 Diabetes For Dummies Rating: 2 out of 5 stars2/5Medical Management of Type 1 Diabetes Rating: 0 out of 5 stars0 ratingsPrescription: Food Rating: 0 out of 5 stars0 ratingsDiabetes Mellitus And Alzheimer’s Disease Link And Risk Factors How to Prevent And Treat Complications And Improve Life Rating: 0 out of 5 stars0 ratingsGenetic Diseases of the Kidney Rating: 0 out of 5 stars0 ratingsAddison’s Disease, A Simple Guide To The Condition, Treatment And Related Conditions Rating: 0 out of 5 stars0 ratingsA Beginner’s Guide to Nutrition for Weight Loss: Learn How to Choose the Correct Foods to Keep You Fit and Healthy Rating: 0 out of 5 stars0 ratingsHypertension, Cardiovascular Disease, Analgesics, and Endocrine Disorders Rating: 0 out of 5 stars0 ratingsThe Changing Landscape of IBD: Emerging Concepts in Patient Management Rating: 0 out of 5 stars0 ratings101 Best Gluten-Free Foods Rating: 0 out of 5 stars0 ratingsUnderstanding Non-Hodgkin Lymphoma. A Guide for Patients, Survivors, and Loved Ones. September 2015 Rating: 0 out of 5 stars0 ratingsThe Heart Attack Handbook: A Prevention & Survival Guide Rating: 0 out of 5 stars0 ratingsNonalcoholic Fatty Liver Disease NAFLD Rating: 0 out of 5 stars0 ratingsHow to Talk to Your Doctor: Getting the Answers and Care You Need Rating: 0 out of 5 stars0 ratingsMastering Your Life With Lupus Rating: 0 out of 5 stars0 ratingsRestaurants and Recipes for the HCG Diet Rating: 0 out of 5 stars0 ratings
Medical For You
The Vagina Bible: The Vulva and the Vagina: Separating the Myth from the Medicine Rating: 5 out of 5 stars5/5Brain on Fire: My Month of Madness Rating: 4 out of 5 stars4/5What Happened to You?: Conversations on Trauma, Resilience, and Healing Rating: 4 out of 5 stars4/5Mediterranean Diet Meal Prep Cookbook: Easy And Healthy Recipes You Can Meal Prep For The Week Rating: 5 out of 5 stars5/5The Emperor of All Maladies: A Biography of Cancer Rating: 5 out of 5 stars5/5The Diabetes Code: Prevent and Reverse Type 2 Diabetes Naturally Rating: 4 out of 5 stars4/5Mating in Captivity: Unlocking Erotic Intelligence Rating: 4 out of 5 stars4/5Adult ADHD: How to Succeed as a Hunter in a Farmer's World Rating: 4 out of 5 stars4/5Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) Rating: 4 out of 5 stars4/5Peptide Protocols: Volume One Rating: 4 out of 5 stars4/5"Cause Unknown": The Epidemic of Sudden Deaths in 2021 & 2022 Rating: 5 out of 5 stars5/5The People's Hospital: Hope and Peril in American Medicine Rating: 4 out of 5 stars4/5The Song of the Cell: An Exploration of Medicine and the New Human Rating: 4 out of 5 stars4/5Women With Attention Deficit Disorder: Embrace Your Differences and Transform Your Life Rating: 5 out of 5 stars5/5Herbal Healing for Women Rating: 4 out of 5 stars4/5Living Daily With Adult ADD or ADHD: 365 Tips o the Day Rating: 5 out of 5 stars5/5WomanCode: Perfect Your Cycle, Amplify Your Fertility, Supercharge Your Sex Drive, and Become a Power Source Rating: 4 out of 5 stars4/5As Nature Made Him: The Boy Who Was Raised as a Girl Rating: 4 out of 5 stars4/5ATOMIC HABITS:: How to Disagree With Your Brain so You Can Break Bad Habits and End Negative Thinking Rating: 5 out of 5 stars5/5Holistic Herbal: A Safe and Practical Guide to Making and Using Herbal Remedies Rating: 4 out of 5 stars4/5Working Stiff: Two Years, 262 Bodies, and the Making of a Medical Examiner Rating: 4 out of 5 stars4/5The 40 Day Dopamine Fast Rating: 4 out of 5 stars4/5Tight Hip Twisted Core: The Key To Unresolved Pain Rating: 4 out of 5 stars4/5
Reviews for Medical Management of Type 2 Diabetes
0 ratings0 reviews
Book preview
Medical Management of Type 2 Diabetes - American Diabetes Association
Director, Book Publishing, Abe Ogden; Managing Editor, Greg Guthrie; Acquisitions Editor, Victor Van Beuren; Editor, Rebekah Renshaw; Production Manager, Melissa Sprott; Composition, ADA; Cover Design, Jody Billert; Printer, United Graphics.
©2012 by the American Diabetes Association, Inc.® All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including duplication, recording, or any information storage and retrieval system, without the prior written permission of the American Diabetes Association.
Printed in the United States of America
1 3 5 7 9 10 8 6 4 2
The suggestions and information contained in this publication are generally consistent with the Clinical Practice Recommendations and other policies of the American Diabetes Association, but they do not represent the policy or position of the Association or any of its boards or committees. Reasonable steps have been taken to ensure the accuracy of the information presented. However, the American Diabetes Association cannot ensure the safety or efficacy of any product or service described in this publication. Individuals are advised to consult a physician or other appropriate health care professional before undertaking any diet or exercise program or taking any medication referred to in this publication. Professionals must use and apply their own professional judgment, experience, and training and should not rely solely on the information contained in this publication before prescribing any diet, exercise, or medication. The American Diabetes Association—its officers, directors, employees, volunteers, and members—assumes no responsibility or liability for personal or other injury, loss, or damage that may result from the suggestions or information in this publication.
Pisymbol.jpg The paper in this publication meets the requirements of the ANSI Standard Z39.48-1992 (permanence of paper).
ADA titles may be purchased for business or promotional use or for special sales. To purchase more than 50 copies of this book at a discount, or for custom editions of this book with your logo, contact the American Diabetes Association at the address below, at booksales@diabetes.org, or by calling 703-299-2046.
American Diabetes Association
1701 North Beauregard Street
Alexandria, Virginia 22311
DOI: 10.2337/9781580404570
Library of Congress Cataloging-in-Publication Data
Medical management of type 2 diabetes / Charles F. Burant, editor.—7th ed.
p. cm.
Includes bibliographical references and index.
ISBN 978-1-58040-457-0 (pbk.)
1. Non-insulin-dependent diabetes. I. Burant, Charles F. II. American Diabetes Association. III. Title: Medical management of type two diabetes.
RC662.18.M43 2012
616.4'624--dc23
2012004880
eISBN: 978-1-58040-491-4
Contents
A Word About This Guide
Contributors to the Seventh Edition
Acknowledgments
Diagnosis and Classification
Highlights
Definition of Diabetes
Diagnosis of Diabetes
Classification of Diabetes
Type 1 diabetes
Type 2 diabetes
Other specific types of diabetes
Stage of disease
Screening for Diabetes
Categories of Increased Risk for Diabetes
Gestational Diabetes Mellitus
Metabolic Syndrome
Evaluation and Classification of Patients Before Treatment
Pathogenesis
Highlights
Genetic and Environmental Factors
Insulin Resistance
Sites of insulin resistance
Mechanisms of insulin resistance
The Fat Cell as an Endocrine Organ
Defects in Insulin Secretion
Factors modulating insulin secretion
Physiological consequences of defective insulin secretion
Conclusion
Management
Highlights
Therapeutic Objectives and Plan
MNT Effectiveness, Process, and Goals
Energy balance and weight loss
Carbohydrate
Protein
Fat
Sodium
Alcohol
Vitamins and minerals
Exercise
Potential benefits of exercise
Precautions and considerations
The exercise prescription
Pharmacologic Intervention
Available agents
Insulins
Long-term combinations of oral agents with insulin
Adjusting insulin dosage in long-term type 2 diabetes
Assessment of Treatment Efficacy
Office methods
Self-monitoring
Special Therapeutic Situations
Highlights
Diabetes in Pregnancy
Diabetes in Youth
Differentiation of type 1 and type 2 diabetes in youth
Screening for type 2 diabetes in youth
Treating type 2 diabetes in youth
Diabetes in Hospitalized and Critically Ill Patients
Major Acute Complications
Hyperosmolar hyperglycemic state
Hypoglycemia
Infection
Detection and Treatment of Chronic Complications
Highlights
Rationale for Optimizing Glycemic Control in Type 2 Diabetes
Accelerated Macrovascular Disease
Diabetes as a cardiovascular risk factor
Screening for cardiovascular disease
Importance of modifying vascular risk factors
Treatment of cardiovascular disease
Diabetic Retinopathy
Stages of diabetic retinopathy
Prevention of vision loss from retinopathy
Treatment of retinopathy
Diabetic Renal Disease
Clinical presentation of nephropathy
Conditions that influence renal function
Prevention and treatment of diabetic renal disease
Diabetic Foot Problems
Causes of diabetic foot problems
Prevention of foot problems
Treatment of foot problems
Diabetic Neuropathies
Diagnosis and treatment of neuropathy
Autonomic neuropathy
Other varieties of diabetic neuropathy
Behavior Change Strategies
Highlights
Influences on Behavior Change
Strategies for Behavior Change
Diabetes Self-Management Support
Redesigning Practice to Support Behavior Change
Summary
A Word About This Guide
Type 2 diabetes is now a worldwide epidemic. The increasing prevalence of obesity and sedentary lifestyles is a driving force in the dramatic increase of type 2 diabetes in our society. If these trends continue, one in three American children born in 2000 faces the probability of developing type 2 diabetes with the attendant risks of morbidity and early mortality. The care of individuals with diabetes will take an increasing portion of expenditures for health care, making this disease a problem for society as well as the individual. Reversing these trends will take a concerted effort in public education directed toward developing better lifestyle habits. The results of several studies have already shown that relatively small lifestyle changes to decrease caloric intake and increase exercise can slow or prevent the transition from impaired glucose tolerance to type 2 diabetes.
Although prevention of type 2 diabetes is a necessary key to addressing the epidemic, for the foreseeable future the practitioner will be caring for an increasing number of patients with diabetes. Since the last edition of this guide, there has been a significant increase in our knowledge of the pathogenesis of type 2 diabetes, its complications, and the options for treatment. Numerous studies have shown that lifestyle changes and pharmacological interventions make a significant impact on the well-being of the patient. Several cardiovascular intervention trials have demonstrated the importance, or even preeminence, of aggressive intervention with medications to control blood pressure and lipids, in addition to glucose, to prevent cardiovascular events in people with type 2 diabetes. It is also becoming clear that when diabetes needs to be treated with medications, multiple drugs can and should be used in combination to control hyperglycemia. The rapid introduction of additional medications when the first therapeutic options fail is of critical importance to control glucose in the short term and to prevent long-term complications. The recent introduction of medications that have unique mechanisms of action has made treatment of type 2 diabetes with oral agents easier and more effective. New insulin analogs and improved delivery devices that make insulin therapy safer and easier to use have increased patient acceptance and compliance. Using all available behavioral and therapeutic tools to improve the care of individuals with type 2 diabetes will likely save lives and decrease microvascular and macrovascular complications. Ultimately, this will improve the lives of those who have or are at risk for diabetes and decrease the cost to society.
This edition of Medical Management of Type 2 Diabetes has been updated to provide state-of-the-art information on these issues by a select group of experts. It also reflects the most recent Clinical Practice Recommendations from the American Diabetes Association, including the diagnostic and classification criteria adopted by the Association in 2004. This book, along with other American Diabetes Association publications, including Medical Management of Type 1 Diabetes, Therapy for Diabetes Mellitus and Related Disorders, Intensive Diabetes Management, and Medical Management of Pregnancy Complicated by Diabetes, were designed to provide health care professionals with the comprehensive information needed to give the best possible medical care to patients with diabetes mellitus.
The American Diabetes Association believes that you will find this book as useful as its predecessors. We hope that it will encourage you to add other American Diabetes Association publications to your library, which can help you manage patients with diabetes more effectively.
CHARLES F. BURANT, MD, PhD
Editor
Contributors to the Seventh Edition
EDITORS
Charles F. Burant, MD, PhD
University of Michigan
Ann Arbor, Michigan
Laura A. Young, MD, PhD
University of North Carolina
Chapel Hill , North Carolina
CONTRIBUTORS
Robert M. Anderson, EdD
University of Michigan
Ann Arbor, Michigan
Komel Benjamin Craig, MPH, RD, LDN
University of North Carolina
Chapel Hill, North Carolina
John B. Buse, MD, PhD
University of North Carolina
Chapel Hill, North Carolina
Martha M. Funnell, MS, RN, CDE
University of Michigan
Ann Arbor, Michigan
Roma Gianchandani, MD
University of Michigan
Ann Arbor, Michigan
William Herman, MD, MPH
University of Michigan
Ann Arbor, Michigan
Robin B. Nwankwo, MPH, RD, CDE
University of Michigan
Ann Arbor, Michigan
Rodica Pop-Busui, MD, PhD
University of Michigan
Ann Arbor, Michigan
Martin Stevens, MD
University of Birmingham
Birmingham, England
Jennifer Wyckoff, MD
University of Michigan
Ann Arbor, Michigan
Acknowledgments
The American Diabetes Association gratefully acknowledges the contributions of the following health care professionals and members of the Association’s Professional Section to previous editions of this work:
Christine A. Beebe, MS, RD, CDE; Nathaniel G. Clark, MD, MS, RD; Mayer B. Davidson, MD; Harold E. Lebovitz, MD; David Nathan, MD; Philip Raskin, MD; Matthew C. Riddle, MD; Harold Rifkin, MD; Robert A. Rizza, MD; F. John Service, MD, PhD; Robert Sherwin, MD; and Bruce R. Zimmerman, MD.
The Association gratefully acknowledges the review by M. Sue Kirkman, MD.
Diagnosis and Classification
Highlights
Definition of Diabetes
Diagnosis of Diabetes
Classification of Diabetes
Type 1 diabetes
Type 2 diabetes
Other specific types of diabetes
Stage of disease
Screening for Diabetes
Categories of Increased Risk for Diabetes
Gestational Diabetes Mellitus
Metabolic Syndrome
Evaluation and Classification of Patients Before Treatment
Highlights
Diagnosis and Classification
• Diabetes is diagnosed by one of the following, confirmed by repeat testing in the absence of unequivocal hyperglycemia :
— Hemoglobin A1c (A1c) ≥6.5%. The test should be performed in a laboratory using a method that is National Glycohemoglobin Standardization Program certified and standardized to the Diabetes Control and Complications Trial assay. Point-of-care A1c assays are not sufficiently accurate to use for diagnostic purposes.
— Fasting Plasma Glucose (FPG) ≥126 mg/dl (7.0 mmol/l). Fasting is defined as no caloric intake for at least 8 h.
— 2-h plasma glucose ≥200 mg/dl (11.1 mmol/l) during an oral glucose tolerance test (OGTT). The test should be performed as described by the World Health Organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.
— In a patient with classic symptoms of hyperglycemia (polydipsia, polyuria, unintentional weight loss) or hyperglycemic crisis, a random plasma glucose ≥200 mg/dl (11.1 mmol/l)
• There are two main types of diabetes: type 1 diabetes, which has absolute insulin deficiency and propensity to develop ketoacidosis; and type 2 diabetes, which has relative insulin deficiency combined with defects in insulin action. Type 2 diabetes is the most common form of diabetes, accounting for 90–95% of the incidence of the disease in Western societies. It is most often found in obese individuals.
• Categories of increased risk for diabetes (prediabetes) describe an intermediate group of individuals with plasma glucose levels higher than normal but lower than those diagnostic of diabetes mellitus. Such individuals are at higher risk for both diabetes and cardiovascular disease. For all three tests, risk is continuous, extending below the lower limit of the range and becoming disproportionately greater at the higher end of the range. They may be identified according to the following criteria:
• A1c 5.7–6.4%
— FPG 100 mg/dl (5.6 mmol/l) to 125 mg/dl (6.9 mmol/l), also known as impaired fasting glucose (IFG)
— 2-h PG during the 75-g OGTT 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l), also known as impaired glucose tolerance (IGT)
• Gestational diabetes mellitus (GDM), glucose intolerance developing during pregnanc. It affects approximately 7% of all pregnancies in the U.S. As many as 50% of women with GDM later develop type 2 diabetes. Screening for GDM is recommended for all women who are not known to have diabetes between the 24th and 28th week of pregnancy. A 75-g OGTT is recommended in the morning after an overnight fast of at least 8 h with plasma glucose measurement fasting and at 1 and 2. High-risk women found to have diabetes at their initial prenatal visit, using standard criteria for diabetes, should receive a diagnosis of overt, not gestational diabetes. The diagnosis of GDM is made when one or more of the following plasma glucose values are exceeded:
— Fasting: ≥92 mg/dl (5.1 mmol/l)
— 1 h: ≥180 mg/dl (10.0 mmol/l)
— 2 h: ≥153 mg/dl (8.5 mmol/)
High-risk women found to have diabetes at their initial prenatal visit, using standard criteria for diabetes, should receive a diagnosis of overt, not gestational diabetes.
DEFINITION OF DIABETES
Diabetes mellitus is a chronic disorder characterized by abnormalities in the metabolism of carbohydrate, protein, and fat. Chronic, sustained exposure to these abnormalities is accompanied by microvascular complications (e.g., retinopathy, nephropathy, and neuropathy), as well as macrovascular complications (e.g., stroke, myocardial infarction, and peripheral arterial disease). It is now recognized that diabetes mellitus encompasses a group of genetically and clinically heterogeneous disorders in which glucose intolerance is the common denominator. Thus, although diabetes mellitus affects the metabolism of all body fuels, its diagnosis depends on identification of specific abnormalities of glycemia.
Because the syndrome of diabetes mellitus encompasses many disorders that differ in pathogenesis, natural history, and responses to treatment, it is important that clinicians and researchers use commonly accepted terminology as well as standardized classification and diagnostic criteria when categorizing patients with glucose intolerance. In January 2010, the American Diabetes Association published diagnostic and classification criteria, replacing its 2003 and 1997 criteria and the criteria of the National Diabetes Data Group published in 1979.
Following the findings of the Diabetes Prevention Program, recognition of degrees of carbohydrate intolerance short of diabetes led to the description of categories of increased risk for diabetes as well as cardiovascular disease (prediabetes). The designation encompasses states described previously as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) and individuals with A1c of 5.7 to 6.4%. Identification of such individuals should facilitate efforts to intervene to reduce the incidence of diabetes and cardiovascular disease.
Following the findings of the Hyperglycemia and Adverse Pregnancy Outcomes Study (HAPO), a large, multinational epidemiologic study that demonstrated that the risk of adverse maternal, fetal, and neonatal outcomes of pregnancy increase as a function of maternal glycemia at 24–28 weeks gestation even within ranges previously considered normal for pregnancy, the ADA developed revised recommendations for the diagnosis of gestational diabetes. These new criteria will significantly increase the prevalence of GDM, but with appropriate treatment, should optimize gestational outcomes for women and their babies.
DIAGNOSIS OF DIABETES
According to current ADA criteria, there are four ways to diagnose diabetes (Table 1.1). Each must be confirmed on a subsequent day by any one of the four methods. When a subject is symptomatic and the random glucose is unequivocally elevated, the diagnosis of diabetes presents no difficulty. In general, if diabetes is initially diagnosed on the basis of symptoms and a random glucose ≥200 mg/dl, it is confirmed with an A1c ≥6.5% or, on a subsequent day, a fasting glucose ≥126 mg/dl. When a subject is without clinical symptoms, the diagnosis of diabetes is more difficult. If the initial diagnosis is suggested on the basis of an A1c ≥6.5% or a fasting glucose ≥126 mg/dl, it is confirmed on a subsequent day with a repeat A1c or fasting glucose.
Table 1.1 Criteria for the Diagnosis of Diabetes
1. A1c ≥6.5%. The test should be performed in a laboratory using a method that is National Glycohemoglobin Standardization Program certified and standardized to the Diabetes Control and Complications Trial assay. Point-of-care A1c assays are not sufficiently accurate to use for diagnostic purposes.
OR
2. Fasting plasma glucose (FPG) ≥126 mg/dl (≥7.0 mmol/l). Fasting is defined as no caloric intake for at least 8 h.
OR
3. 2-h plasma glucose ≥200 mg/dl (≥11.1 mmol/l) during an oral glucose tolerance test (OGTT). The test should be performed as described by the World Health Organization (WHO), using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.
OR
4. In a patient with classic symptoms of hyperglycemia (polydipsia, polyuria, unintentional weight loss) or hyperglycemic crisis, a random plasma glucose ≥200 mg/dl (11.1 mmol/l).
A clear advantage of the A1c test for the diagnosis of diabetes is its greater convenience—the patient does not need to fast. In addition, there is less day-to-day variation in A1c and greater preanalytic stability. Relative disadvantages include its greater cost as compared to glucose and its limited availability in some regions of the developing world. In addition, although highly specific for the diagnosis of diabetes, A1c is less sensitive than fasting glucose or 2-h PG. In addition, A1c may be an inaccurate measure of average glycemia in patients with hemoglobinopathies, thalassemia syndromes, states of increased red cell turnover, including those related to hemolysis, erythropoietin therapy, or transfusion, and in patients with iron deficiency. Uremia and hyperbilirubinemia may also interfere with some assays. In such patients, the diagnosis of diabetes must employ glucose criteria.
The oral glucose tolerance test (OGTT) is performed only in patients with elevated but nondiagnostic A1c or fasting glucose levels in whom there is a high index of suspicion for diabetes. Such patients might, for example, have an A1c of 6.3% or a fasting glucose of 115 mg/dl and evidence of cardiovascular disease or diffuse symmetric peripheral polyneuropathy. In such patients, the OGTT may be informative. The OGTT is essentially never indicated in patients with symptoms and random glucose levels ≥200 mg/dl or in patients with A1c ≥6.5% or fasting glucose level ≥126 mg/dl.
CLASSIFICATION OF DIABETES
Having established a diagnosis of diabetes, the next task is to classify the type. The purpose of classification is to differentiate and identify the various forms of the disease. The first generally accepted classification system was developed by the National Diabetes Data Group (NDDG) and published in 1979. The World